Zenas BioPharma Inc.
ZBIO | NASDAQ
$25.93
-$2.53 (-8.89%)
At close: Nov 5, 2026, 4:00 PM ET
$24.56
-$1.37 (-5.28%)
After-hours:
Nov 5, 2026, 6:19 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 196.58M | 500.22M | 110.64M | 115.57M | 44.01M | 196.55M | 319.74M | 360.04M | 183.93M | 37.15M | 56.86M | 72.31M |
Short-Term Investments | 446.55M | 216.98M | 232.55M | 175.32M | 229.27M | 115.83M | 31.02M | 26.76M | n/a | n/a | n/a | n/a |
Long-Term Investments | 30.76M | 1.34M | 17.27M | 10.72M | 1.61M | 1.84M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 16.29M | 15.06M | 13.81M | 13.8M | 11.8M | 12.85M | 12.86M | 9.11M | 10.65M | 8.5M | 7.36M | 5.97M |
Receivables | 800K | 1.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 9.87M | 11.86M | 7.98M | 5.76M | 1.3M | 5.43M | 5.16M | 6.98M | 1.2M | 2.55M | 2.95M | n/a |
Total Current Assets | 653.79M | 730.16M | 351.17M | 296.64M | 278.6M | 317.81M | 355.92M | 393.78M | 188.6M | 39.71M | 59.8M | 76.68M |
Property-Plant & Equipment | 844K | 1.12M | 1.39M | 857K | 1.07M | 1.28M | 1.19M | 545K | 706K | 847K | 1.01M | 1.15M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 47.9M | 17.52M | 32.47M | 25.38M | 14.48M | 15.96M | 14.05M | 9.65M | 11.35M | 9.35M | 8.38M | 7.12M |
Total Assets | 701.69M | 747.68M | 383.64M | 322.02M | 293.09M | 333.77M | 369.97M | 403.43M | 199.95M | 49.05M | 68.18M | 83.79M |
Account Payables | 7.59M | 8.94M | 7.11M | 6.44M | 7.93M | 20.02M | 17.14M | 15.08M | 8.36M | 8.83M | 5.4M | 2.28M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 823K | 1.04M | 1.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 47.57M | 45.44M | 41.23M | 8.76M | 6.05M | 3.38M | 8.31M | 6.19M | 530K | 3.72M | 5.12M | 4.12M |
Total Current Liabilities | 65.82M | 61.16M | 62.65M | 52.42M | 53.24M | 49.13M | 57.29M | 44M | 39.11M | 30.33M | 23.26M | 15.56M |
Long-Term Debt | 388.75M | 350.62M | 78.64M | n/a | n/a | n/a | n/a | n/a | n/a | 20.99M | 20.3M | 20M |
Other Long-Term Liabilities | n/a | n/a | n/a | 72.99M | n/a | n/a | n/a | n/a | n/a | 250.09M | 250.09M | 250.09M |
Total Long-Term Liabilities | 388.78M | 350.69M | 78.85M | 73.17M | 215K | 317K | 218K | n/a | 14K | 271.21M | 270.64M | 270.47M |
Total Liabilities | 454.59M | 411.85M | 141.5M | 125.59M | 53.46M | 49.45M | 57.51M | 44M | 39.12M | 301.55M | 293.9M | 286.02M |
Total Debt | 389.6M | 351.73M | 79.96M | 798K | 1.01M | 1.23M | 1M | 384K | 508K | 21.64M | 21.11M | 20.96M |
Book Value | 247.1M | 335.83M | 242.14M | 196.43M | 239.63M | 284.32M | 312.46M | 359.44M | 160.83M | -252.5M | -225.72M | -202.23M |
Book Value Per Share | 3.92 | 6.04 | 5.21 | 4.66 | 5.72 | 6.80 | 7.48 | 8.60 | 4.20 | -6.59 | -5.89 | -4.84 |
Common Stock | 6K | 6K | 5K | 4K | 4K | 4K | 4K | 4K | 1K | 1K | n/a | 1K |
Retained Earnings | -957.57M | -846.12M | -765.13M | -524.69M | -473.19M | -420.96M | -387.39M | -334.79M | -296.18M | -258.2M | -230.4M | -205.82M |
Comprehensive Income | -1.14M | -377K | -64K | -69K | -94K | 141K | 194K | 54K | 104K | 74K | 37K | 124K |
Shareholders Equity | 247.1M | 335.83M | 242.14M | 196.43M | 239.63M | 284.32M | 312.46M | 359.44M | 160.83M | -252.5M | -225.72M | -202.23M |
Total Investments | 477.31M | 218.32M | 249.82M | 186.04M | 230.89M | 117.66M | 31.02M | 26.76M | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ZBIO